BPA Call W9114F24A0009-W9114F24F0078

Award Date 9/30/24
Potential Completion Date 9/30/24
Potential Value $6.2K
Federal Agency
Medical Command
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Germany
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
4
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of the Army Medical Command awarded a $39,203 firm fixed price blanket purchase agreement call to Biomerieux Deutschland GMBH for decentralized calls for July 2023. Biomerieux Deutschland GMBH, located in Germany, will provide unspecified products or services to the Army Medical Command under the terms of this BPA call. No additional details were provided regarding the scope of work. The Army Medical Command manages healthcare support for soldiers and other beneficiaries around...
This contract award is for a BPA call to Biomerieux Deutschland GMBH, a German company that provides medical and laboratory products and services to the U.S. Department of Defense. The $49,911.73 award is for "DECENTRALIZED CALLS FROM OCT23 TO JAN24" to support the U.S. Army Medical Command. Biomerieux Deutschland GMBH has previously received awards from the Army Medical Command and Defense Health Agency to supply reagents, testing equipment, and systems for military medical...
The Department of the Army Medical Command awarded a $220,290 firm fixed price call against its FY23 Centralized BPA to Biomerieux Deutschland GMBH for the period of September 6-15, 2023. As a prime contractor under the Army's centralized indefinite-delivery/indefinite-quantity vehicle, Biomerieux Deutschland GMBH will provide unspecified medical products or services to support the Army Medical Command. Headquartered in Germany, Biomerieux Deutschland GMBH will perform the work under this call...
This federal contract award is for the lease of a MALDI-TOF mass spectrometer by the U.S. Army Medical Command (MEDCOM) to Biomerieux Deutschland GMBH, a foreign-owned, for-profit organization based in Germany. The contract, valued at $409,211.06, was awarded on April 17, 2015 with a final completion date of May 19, 2020. The contract has no set-aside designation, indicating open competition. Biomerieux Deutschland GMBH is the prime contractor on this award and has an established relationship...
This is a firm fixed-price contract awarded by the Department of the Army Medical Command to Biomerieux Deutschland GMBH, a German-owned for-profit organization, to provide KIT BIOFIRE GI PAN 30S. The contract has a potential value of $149,440.69 and a period of performance ending on May 22, 2019. No set-aside designation was used. Biomerieux Deutschland GMBH is a prime contractor that has received previous awards from the Army Medical Command and Defense Health Agency to supply medical and...
Biomerieux Deutschland GMBH has been awarded a firm fixed price blanket purchase agreement (BPA) call contract by the Defense Health Agency (DHA) to provide reagents for laboratory testing. The contract has a potential value of approximately $37,000 and requires delivery of the reagents to a location in Eno Valley, North Carolina by September 30, 2023. No set-aside provisions were applied to this award. Biomerieux Deutschland GMBH will serve as the prime contractor to fulfill the agency's...
This firm fixed price blanket purchase agreement (BPA) call contract was awarded by the Defense Health Agency on April 25, 2023 to Biomerieux Deutschland GMBH for the delivery of reagents for laboratory testing. Valued at approximately $10,739, the contract has a period of performance through September 30, 2023. No set-aside designation was applied to this procurement. Biomerieux Deutschland GMBH, located in Almanya, will provide the requested reagents in support of the Defense Health Agency's...
The Department of the Army Medical Command awarded Biomerieux Inc., a foreign-owned for-profit manufacturer, a 6-month firm-fixed-price purchase order contract valued at $247,451.00 for a microbial analyzer and related testing services. The contract does not have a set-aside designation. Biomerieux Inc. has previously provided clinical diagnostic testing products, equipment, and services to federal agencies such as the Departments of Veterans Affairs, Defense, Agriculture, and Health and Human...
This is a firm fixed-price purchase order awarded by the Department of the Army Medical Command to Biomerieux Inc., a foreign-owned, for-profit manufacturer of goods, for the provision of a microbiology analyzer and associated maintenance and supplies. The contract has a potential value of $105,805.80 and a completion date of October 31, 2023. No set-aside designation is mentioned. Biomerieux Inc. is a worldwide leader in in vitro diagnostics, offering clinical testing solutions and equipment,...
The Department of the Army Medical Command awarded a $239,903 firm-fixed price purchase order to Biomerieux Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic solutions. The contract is for the provision of the BACT/ALERT FA PLUS (100 per) microbiology testing system and associated reagents. This requirement was initially a sources sought notice to determine the availability of qualified sources for an automated blood culture monitoring and sepsis detection system to support...
  • W9114F24A0009
    Blanket Purchase Agreement
  • W9114F24A0009-W9114F24F0078
    BPA Call

The U.S. Department of the Army Medical Command (MEDCOM) awarded a Blanket Purchase Agreement (BPA) call to Biomerieux Deutschland GMBH, a German-based company, on September 30, 2024. The firm fixed-price call, valued at $6,224.48, is part of a larger $2 million BPA awarded on September 20, 2022, which is designed to supply laboratory items to support U.S. military medical facilities in Europe. The BPA call involves the delivery of reagents, medical supplies, and laboratory equipment, such as VITEK microbiology systems and MALDI-TOF mass spectrometry systems, to locations in Germany and North Carolina. Biomerieux Deutschland GMBH, a foreign-owned, for-profit organization, has provided a range of sophisticated medical and laboratory products to the U.S. military through multiple contract awards, primarily supporting facilities in Germany.

Generated 12/30/24, 1:33 PM